"Parkinson Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Descriptor ID |
D010300
|
MeSH Number(s) |
C10.228.140.079.862.500 C10.228.662.600.400 C10.574.812
|
Concept/Terms |
Parkinson Disease- Parkinson Disease
- Idiopathic Parkinson's Disease
- Lewy Body Parkinson Disease
- Lewy Body Parkinson's Disease
- Primary Parkinsonism
- Parkinsonism, Primary
- Parkinson Disease, Idiopathic
- Parkinson's Disease
- Parkinson's Disease, Idiopathic
- Parkinson's Disease, Lewy Body
- Idiopathic Parkinson Disease
- Paralysis Agitans
|
Below are MeSH descriptors whose meaning is more general than "Parkinson Disease".
Below are MeSH descriptors whose meaning is more specific than "Parkinson Disease".
This graph shows the total number of publications written about "Parkinson Disease" by people in this website by year, and whether "Parkinson Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 0 | 1 | 1 |
2003 | 1 | 0 | 1 |
2006 | 1 | 2 | 3 |
2007 | 2 | 0 | 2 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 0 | 1 | 1 |
2012 | 2 | 0 | 2 |
2013 | 1 | 1 | 2 |
2014 | 1 | 0 | 1 |
2016 | 2 | 0 | 2 |
2017 | 2 | 0 | 2 |
2018 | 6 | 0 | 6 |
2019 | 2 | 0 | 2 |
2020 | 3 | 1 | 4 |
2021 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
2024 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parkinson Disease" by people in Profiles.
-
CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson's Disease Associated Protein. J Chem Inf Model. 2024 Nov 25; 64(22):8521-8536.
-
Unraveling the AKT/ERK cascade and its role in Parkinson disease. Arch Toxicol. 2024 Oct; 98(10):3169-3190.
-
Computer-Aided Design and Biological Evaluation of Diazaspirocyclic D4R Antagonists. ACS Chem Neurosci. 2024 Jun 19; 15(12):2396-2407.
-
Remote and in-person research education for people with Parkinson's disease and their care partners. Fam Syst Health. 2023 03; 41(1):26-43.
-
An altered microbiome in a Parkinson's disease model Drosophila melanogaster has a negative effect on development. Sci Rep. 2021 12 08; 11(1):23635.
-
Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson's Disease. J Neuroimmune Pharmacol. 2021 09; 16(3):667-678.
-
Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease. Acta Neuropathol. 2020 09; 140(3):341-358.
-
Health-related quality of life changes after the merging yoga and occupational therapy for Parkinson's disease program: A mixed-methods study. Complement Ther Clin Pract. 2020 May; 39:101156.
-
Adult Spinal Deformity Surgery in Patients With Movement Disorders: A Propensity-matched Analysis of Outcomes and Cost. Spine (Phila Pa 1976). 2020 Mar 01; 45(5):E288-E295.
-
Evolving nanoformulation strategies for diagnosis and clinical interventions for Parkinson's disease. Drug Discov Today. 2020 02; 25(2):392-405.